To investigate the potential of Hepta-ANGPT1 as a therapy for POAG, and explore the effects of localized treatment, 1 μg of Hepta-ANGPT1 or PBS vehicle was delivered to the eyes of adult male C57Bl/6J mice by bilateral intravitreal injection. Here, ANGPT1 is linked to open-angle glaucoma.